Drug Development Solutions

  1. Testing At WuXi Advanced Therapies 3/21/2024

    Learn how a partner offering a comprehensive suite of integrated testing services designed to navigate the complexities of cell and gene therapies is critical for accelerating development timelines.

  2. Plug Into The Future Of Bispecific Antibodies

    Lonza’s bYlok® technology is a true plug-and-play solution to bispecific antibody engineering – high product quality, simplified processes, unlocking the future.

  3. Testing Solutions For RNA-Based Products 4/12/2024

    RNA-based therapeutics have become structurally complex and require sophisticated analytical methodologies. Learn how SGS can help you meet regulatory standards and ensure product efficacy.

  4. Integrated Programs To Bridge Molecules From Discovery Into Clinical Development 1/4/2023

    A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.

  5. Surfactant Analysis Services

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

  6. ADCs: From Design To Development 1/4/2024

    Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.

  7. Quantitative PCR (qPCR) 2/5/2025

    With decades of experience in molecular assay development for biomarker and PK/PD studies, our scientific team collaborates closely with sponsors to design tailored solutions.

  8. Small Molecule Analytical Testing Services 9/27/2024

    With a comprehensive suite of capabilities, experienced professionals, and a proven track record, SK pharmteco ensures confidence and quality at every stage of the product lifecycle.

  9. Peptide Development Strategies 10/27/2022

    Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.

  10. Leveraging Proprietary CDO Platforms

    Explore how a suite of proprietary CDO platforms for BsAbs, transient expression, developability assessment, and more can help optimize every stage of development and accelerate your project timeline.